Titre : Flavonols

Flavonols : Questions médicales fréquentes

Termes MeSH sélectionnés :

Extremities
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Flavonols : Questions médicales les plus fréquentes", "headline": "Flavonols : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Flavonols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-18", "dateModified": "2025-02-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Flavonols" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Flavonoïdes", "url": "https://questionsmedicales.fr/mesh/D005419", "about": { "@type": "MedicalCondition", "name": "Flavonoïdes", "code": { "@type": "MedicalCode", "code": "D005419", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Kaempférols", "alternateName": "Kaempferols", "url": "https://questionsmedicales.fr/mesh/D044949", "about": { "@type": "MedicalCondition", "name": "Kaempférols", "code": { "@type": "MedicalCode", "code": "D044949", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.388" } } }, { "@type": "MedicalWebPage", "name": "Quercétine", "alternateName": "Quercetin", "url": "https://questionsmedicales.fr/mesh/D011794", "about": { "@type": "MedicalCondition", "name": "Quercétine", "code": { "@type": "MedicalCode", "code": "D011794", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.777" } } }, { "@type": "MedicalWebPage", "name": "Rutoside", "alternateName": "Rutin", "url": "https://questionsmedicales.fr/mesh/D012431", "about": { "@type": "MedicalCondition", "name": "Rutoside", "code": { "@type": "MedicalCode", "code": "D012431", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.888" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "O-(bêta-Hydroxyéthyl)rutosides", "alternateName": "Hydroxyethylrutoside", "url": "https://questionsmedicales.fr/mesh/D006896", "about": { "@type": "MedicalCondition", "name": "O-(bêta-Hydroxyéthyl)rutosides", "code": { "@type": "MedicalCode", "code": "D006896", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.888.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Flavonols", "alternateName": "Flavonols", "code": { "@type": "MedicalCode", "code": "D044948", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Changjie Xu", "url": "https://questionsmedicales.fr/author/Changjie%20Xu", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Kunsong Chen", "url": "https://questionsmedicales.fr/author/Kunsong%20Chen", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Xian Li", "url": "https://questionsmedicales.fr/author/Xian%20Li", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Wei Xue", "url": "https://questionsmedicales.fr/author/Wei%20Xue", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals, Guizhou University, Guiyang, 550025, China. wxue@gzu.edu.cn." } }, { "@type": "Person", "name": "Nguyen Xuan Nhiem", "url": "https://questionsmedicales.fr/author/Nguyen%20Xuan%20Nhiem", "affiliation": { "@type": "Organization", "name": "Institute of Marine Biochemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "[Possibilities of orthopedic technical care for extremity lengthening and reconstruction].", "datePublished": "2023-07-25", "url": "https://questionsmedicales.fr/article/37491653", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00132-023-04424-z" } }, { "@type": "ScholarlyArticle", "name": "From replantation to transplantation: The evolution of orthoplastic extremity reconstruction.", "datePublished": "2022-11-30", "url": "https://questionsmedicales.fr/article/36413095", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jor.25488" } }, { "@type": "ScholarlyArticle", "name": "Lower-Extremity Vascular Ulcers: Assessment and Approaches to Management.", "datePublished": "2023-06-11", "url": "https://questionsmedicales.fr/article/37541716", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.mcna.2023.05.003" } }, { "@type": "ScholarlyArticle", "name": "Venous Reconstruction in Extremity Soft Tissue Sarcoma Is Not Essential.", "datePublished": "2023-01-02", "url": "https://questionsmedicales.fr/article/36592476", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/15385744221150737" } }, { "@type": "ScholarlyArticle", "name": "Functional Muscle Transfer after Oncologic Extremity Resection.", "datePublished": "2022-06-29", "url": "https://questionsmedicales.fr/article/35768008", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-1887-7530" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Benzopyranes", "item": "https://questionsmedicales.fr/mesh/D001578" }, { "@type": "ListItem", "position": 6, "name": "4H-1-Benzopyran-4-ones", "item": "https://questionsmedicales.fr/mesh/D002867" }, { "@type": "ListItem", "position": 7, "name": "Flavonoïdes", "item": "https://questionsmedicales.fr/mesh/D005419" }, { "@type": "ListItem", "position": 8, "name": "Flavonols", "item": "https://questionsmedicales.fr/mesh/D044948" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Flavonols - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Flavonols", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Flavonols", "description": "Comment détecte-t-on les flavonols dans les aliments ?\nQuels tests mesurent les niveaux de flavonols dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Extremities&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Flavonols", "description": "Les flavonols provoquent-ils des symptômes ?\nQuels effets des flavonols sur la santé ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Extremities&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Flavonols", "description": "Comment les flavonols aident-ils à prévenir les maladies ?\nQuels aliments sont riches en flavonols ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Extremities&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Flavonols", "description": "Les flavonols sont-ils utilisés en médecine ?\nComment les flavonols aident-ils dans le traitement du cancer ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Extremities&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Flavonols", "description": "Y a-t-il des complications liées aux flavonols ?\nLes flavonols peuvent-ils causer des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Extremities&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Flavonols", "description": "Qui devrait éviter les flavonols ?\nLes flavonols sont-ils sûrs pour les femmes enceintes ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Extremities&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on les flavonols dans les aliments ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les flavonols peuvent être détectés par chromatographie et spectrométrie de masse." } }, { "@type": "Question", "name": "Quels tests mesurent les niveaux de flavonols dans le sang ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins spécifiques peuvent quantifier les flavonols et leurs métabolites." } }, { "@type": "Question", "name": "Les flavonols provoquent-ils des symptômes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "En général, les flavonols ne provoquent pas de symptômes, mais des allergies peuvent survenir." } }, { "@type": "Question", "name": "Quels effets des flavonols sur la santé ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les flavonols peuvent réduire l'inflammation et améliorer la santé cardiovasculaire." } }, { "@type": "Question", "name": "Comment les flavonols aident-ils à prévenir les maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils agissent comme antioxydants, réduisant le stress oxydatif et le risque de maladies." } }, { "@type": "Question", "name": "Quels aliments sont riches en flavonols ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les oignons, le thé, les baies et le chocolat noir sont de bonnes sources de flavonols." } }, { "@type": "Question", "name": "Les flavonols sont-ils utilisés en médecine ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les flavonols sont étudiés pour leurs effets bénéfiques sur diverses maladies." } }, { "@type": "Question", "name": "Comment les flavonols aident-ils dans le traitement du cancer ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent inhiber la croissance tumorale et améliorer l'efficacité des traitements." } }, { "@type": "Question", "name": "Y a-t-il des complications liées aux flavonols ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des interactions médicamenteuses peuvent survenir, mais elles sont rares." } }, { "@type": "Question", "name": "Les flavonols peuvent-ils causer des effets secondaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "En général, ils sont sûrs, mais des doses élevées peuvent entraîner des troubles digestifs." } }, { "@type": "Question", "name": "Qui devrait éviter les flavonols ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes allergiques aux flavonoïdes devraient limiter leur consommation de flavonols." } }, { "@type": "Question", "name": "Les flavonols sont-ils sûrs pour les femmes enceintes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "En général, les flavonols sont considérés comme sûrs, mais une consultation médicale est conseillée." } } ] } ] }

Sources (6813 au total)

[Possibilities of orthopedic technical care for extremity lengthening and reconstruction].

Orthopedic technical care plays a crucial role in improving function and mobility for patients undergoing limb lengthening and reconstruction. The treatment strategy is based on a precise classificati... The selection of orthopedic aids depends on the specific deformity, its classification and the individual needs of the patient. Through interdisciplinary decision-making and customized adaptations of ...

Venous Reconstruction in Extremity Soft Tissue Sarcoma Is Not Essential.

Limb salvage is an important concern following complete oncologic resection for extremity soft tissue sarcoma (STS). Vascular reconstruction is essential for limb salvage. The purpose of this study wa... This is a retrospective, multi-center, case series of consecutive patients who underwent vascular reconstruction during extremity STS resection at 2 major centers in Korea. Demographics, reconstructio... From March 2005 to December 2020, 43 patients underwent vascular reconstructions during STS resection. Among the patients, 22 (51.2%) received arterial only, and 21 (48.8%) received simultaneous arter... Patency rates were poorer in venous reconstruction than in arterial reconstruction. In terms of arterial patency and postoperative complication, the role of simultaneous arterial and venous reconstruc...

Functional Muscle Transfer after Oncologic Extremity Resection.

Functional muscle transfer (FMT) can provide wound closure and restore adequate muscle function for patients with oncologic extremity defects. Herein we describe our institutional experience with FMT ... A single-institution retrospective review was performed, including all patients who received FMT after oncological resection from 2005 to 2021. For the systematic review and meta-analysis, PubMed, Coc... The meta-analysis consisted of seven studies with 70 patients overall, demonstrating a mean Medical Research Council (MRC) score of 3.78 (95% confidence interval: 2.97-4.56;... FMT after oncological resection may contribute to improved extremity function. Careful consideration of risk factors and preoperative planning is imperative for successful FMT outcomes....

The clinical outcomes and prognostic factors of dedifferentiated central chondrosarcoma in extremities.

This study was to analyze the clinical outcomes and prognostic factors of dedifferentiated central chondrosarcomas (DCCS) in extremities.... A retrospective study was conducted on 49 patients (27 males, 22 females) who underwent surgical treatment between January 2001 and March 2023 in our institution. All patients were diagnosed with dedi... 49 patients were included in this retrospective study and there were no patients lost in the follow-up period. The median diagnosis age of all patients was 57 years old (ranging from 17 to 87) and the... Dedifferentiated central chondrosarcomas in extremities still had a grave prognosis. Metastasis, pathological fracture, Enneking staging, and surgical margin were independent risk factors for prognosi... IV Therapic....

The Prognostic Value of Serum Biomarkers for Survival of Children with Osteosarcoma of the Extremities.

Osteosarcoma is a highly aggressive malignant bone tumor that affects mainly adolescents and young adults. We analyzed serum biomarkers for their prognostic significance in children with osteosarcoma.... In this retrospective study, we investigated the prognostic factors in 210 children who were treated for appendicular osteosarcoma, including patient age and sex, tumor site and size (≥8 cm or <8 cm),... A multivariate Cox regression model showed that high level of AP [HR of 1.73; 95% CI, 1.02 to 2.94], poor chemotherapy-induced tumor necrosis [HR of 2.40; 95% CI, 1.41 to 4.08] and presence of metasta... AP and ESR can identify osteosarcoma-diagnosed children with a greater risk of death and local recurrence, respectively....

Impact of delay of local control in nonmetastatic extremity primary osteosarcoma.

The timing of local control (LC) is not well studied in osteosarcoma. We assessed the impact of the delay of LC on the survival outcome of patients with osteosarcoma.... We conducted a retrospective analysis of children (≤18 years) with nonmetastatic extremity primary osteosarcoma at King Hussein Cancer Center from January 2005 until March 2020. Patients' demographics... Eighty-two patients were included; 41 (50%) were females; the median age was 12.5 years (range: 5.9-18). Sixty-four patients (78%) underwent LC by limb-salvage surgery. Fifteen patients (18%) had a de... Our findings suggest that delay in LC could have an impact on the outcomes in patients with osteosarcoma. However, further investigations involving larger sample sizes and longer follow-up are necessa...